Welcome to the February issue of Pathway, a monthly magazine designed for anyone interested in their health and wellbeing and in the integral role that pathology plays in the diagnosis, treatment and management of diseases.
This month’s issue of Pathway looks at the following:
Australasia's premier multi-disciplinary pathology conference took place this weekend. Path Update was jam packed with a great scientific program, expert speakers and social events.
World-first Australian pharmacogenetics trial for childhood cancer
Commencing this week, a new trial will assess whether there is a decline in adverse drug reactions following PGx screening in paediatric cancer patients.
Lockdowns floods and bushfires spark a mesothelioma warning
There are concerns over the number of Australians who may have been exposed to asbestos during recent crises in Australia, raising concerns about diseases such as mesothelioma.
Proteomics will revolutionise personalised treatment
Speaking at Pathology Update, Prof Ed Nice says proteomics is a game-changer in precision and personalised medicine, and will accelerate progress in this area over the next five years
